#AASLD2023 Archives - MediaMedic

Revisiting the “Gut-Liver-Brain Axis” through the Lens of Bile Acids – Key Advances and Prospects in Basic and Clinical Research

By Lisa Cui 2024.01.19

AASLD Roundtable Discussion: Revisiting the "Gut-Liver-Brain Axis" through the Lens of Bile Acids - Key Advances and Prospects in Basic and Clinical Research Editor's Note: The recently concluded AASLD 2023,…

AASLD Interview | Dr.Fengmin Lu: Exploring Interferon Cure Advantages in Chronic Hepatitis B, Delving into Mechanisms to Guide New Drug Development

By Mourabit Halima 2024.01.19

Editor's Note: At the just-concluded Annual Summit of Hepatology, the American Association for the Study of Liver Diseases (AASLD2023), Professor Fengmin Lu's team from Peking University presented three contributions (1…

AASLD Exclusive Interview | Professor Monica Tincopa: Four New Insights into the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

By Peng Longmei 2024.01.19

Editor’s Note: At the recently concluded international annual grand event in the field of hepatology - the American Association for the Study of Liver Diseases Annual Meeting (AASLD 2023), Professor…

AASLD Voice of China: Dr. Liang Peng’s Hepatitis B Research Highlights Safety and Efficacy of Antiviral Therapy for ‘Healthy’ Carriers

By Lisa Cui 2024.01.17

Editor's Note: From November 10th to 14th, 2023, the annual international highlight event in the field of hepatology, the 2023 American Association for the Study of Liver Diseases (AASLD) Annual…

Voice of China | Professor Jidong Jia and Professor Hong You’s Team: Carvedilol Combined with Antiviral Treatment Can Delay the Progression of Moderat

By Mourabit Halima 2024.01.17

Editor's Note: Portal hypertension is the main pathophysiological cause of decompensation events in patients with cirrhosis and is a major driver of liver function deterioration. Non-selective β-blockers (NSBBs) are widely…

AASLD Voice of China| Dr. Xianbo Wang’s Team: Multiple Studies in the Field of Primary Biliary Cholangitis Presented at AASLD Meeting

By Lisa Cui 2024.01.17

Editor's Note: The Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) was held in Boston, USA, from November 10 to 14, 2023. Dr. Xianbo Wang's…

AASLD Voice of China| Dr. Song Yang’s Team: Survival Prediction in Chinese Alcohol- Related Liver Disease — Sarcopenia is an Independent Factor, MELD

By Mourabit Halima 2024.01.17

Editor's Note: From November 10th to 14th, the annual highlight event in the field of hepatology, the American Association for the Study of Liver Diseases (AASLD) 2023 Annual Meeting, took…

AASLD 2023 Highlights: Conference Overview and Special Topics Collection

By Mourabit Halima 2024.01.16

Editor's Note: From November 10th to 14th, the annual grand event in the field of hepatology, the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 2023, is…

AASLD Hot Updates on MASLD from the 2023 Annual Meeting

By Kenzy Nour 2024.01.16

Editor's Note: On November 7, 2023, at 12:30 PM local time in Boston, the American Association for the Study of Liver Diseases (AASLD) held its sole pre-conference press briefing on…

AASLD 2023 | Professor Zhihua Liu’s Team: Revealing the Dynamic Changes in T-Cell Immunity during Pregnancy and Postpartum Period in Women with Chronic HBV Infection and Its Relationship with Infection Status

By Mourabit Halima 2024.01.14

Editor's Note: The 2023 American Association for the Study of Liver Diseases (AASLD) Annual Meeting has recently concluded in Boston, USA. A study in the field of immunology related to hepatitis…